Evolent Health, Inc.

NYSE EVH

Evolent Health, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2024: USD 21.56

Evolent Health, Inc. Revenue Per Share is USD 21.56 for the Trailing 12 Months (TTM) ending September 30, 2024, a 29.78% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Evolent Health, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 16.61, a 23.83% change year over year.
  • Evolent Health, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 13.41, a 22.47% change year over year.
  • Evolent Health, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 10.95, a -5.89% change year over year.
  • Evolent Health, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 11.64, a 17.46% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
NYSE: EVH

Evolent Health, Inc.

CEO Mr. Seth Barrie Blackley
IPO Date June 5, 2015
Location United States
Headquarters 800 North Glebe Road
Employees 4,700
Sector Health Care
Industries
Description

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Similar companies

PRVA

Privia Health Group, Inc.

USD 21.00

1.25%

SLP

Simulations Plus, Inc.

USD 28.76

-0.48%

NRC

National Research Corporation

USD 16.93

-1.97%

DH

Definitive Healthcare Corp.

USD 3.92

-0.25%

CERT

Certara, Inc.

USD 10.74

-2.10%

HCAT

Health Catalyst, Inc.

USD 5.90

-9.09%

HQY

HealthEquity, Inc.

USD 103.61

1.76%

FORA

Forian Inc.

USD 2.08

-0.48%

StockViz Staff

January 15, 2025

Any question? Send us an email